Helixate NexGen Interactions
There are 10 drugs known to interact with Helixate NexGen (antihemophilic factor), along with 5 disease interactions. Of the total drug interactions, 1 is major, and 9 are moderate.
- View Helixate NexGen disease interactions (5)
Medications known to interact with Helixate NexGen
Note: Showing generic names only.
Helixate NexGen disease interactions
There are 5 disease interactions with Helixate NexGen (antihemophilic factor) which include:
- cardiovascular complications
- inhibitory antibodies
- blood isoagglutinin
- immunodeficiency
- thromboembolic events
Report options
More about Helixate NexGen (antihemophilic factor)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Lysteda
Lysteda (tranexamic acid) is used to treat heavy menstrual bleeding. Includes Lysteda side effects ...
Hemlibra
Hemlibra is a monoclonal antibody that functions in place of a natural blood-clotting factor that ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
DDAVP
DDAVP is used for diabetes insipidus, hemophilia a, primary nocturnal enuresis, von Willebrand Disease
Qfitlia
Qfitlia is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia b with ...
Altuviiio
Altuviiio is a once-weekly recombinant fact VIII replacement therapy used by hemophilia A patients ...
Cyklokapron
Cyklokapron is used for bleeding disorder, factor ix deficiency, hemophilia a
Hympavzi
Hympavzi (marstacimab-hncq) may be used to prevent or reduce the frequency of bleeding episodes ...
Emicizumab
Emicizumab is used for hemophilia a, hemophilia a with inhibitors
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.